Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study

Completed

Conditions: Hemophilia A
Hemophilia B

First Posted Date: 2009-07-10

Last Posted Date: 2012-12-10

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 200

Registration Number: NCT00936312

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇩🇪
University Clinic Bonn, Bonn, Germany
🇮🇹
A. Bianchi Bonomi Hemophilia Center, Milan, Italy

and more 8 locations

Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study

Completed

Conditions: Hemophilia A
Hemophilia B

First Posted Date: 2009-07-10

Last Posted Date: 2012-12-10

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 22

Registration Number: NCT00936845

Locations: 🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇺🇸
Mountain States Regional Hemophilia and Thrombosis Center, Aurora, Colorado, United States
🇺🇸
Georgetown University Hospital, Washington, District of Columbia, United States

and more 16 locations

Assessing Anterior Cingulate Brain Activity in People With Late-Life Depression

Completed

Conditions: Depression

Interventions: Drug: Escitalopram

First Posted Date: 2009-06-23

Last Posted Date: 2015-08-11

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 76

Registration Number: NCT00926653

Locations: 🇺🇸
New York Presbyterian-Weill Cornell Medical College, White Plains, New York, United States

Aging Brain Changes, Executive Dysfunction and Depression

Phase 4

Completed

Conditions: Depression

Interventions: Drug: Escitalopram

First Posted Date: 2009-06-11

Last Posted Date: 2017-05-12

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 116

Registration Number: NCT00918684

A Study to Evaluate the Safety and Efficacy of Dasatinib (Sprycel) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Phase 2

Terminated

Conditions: Diffuse Large B-cell Lymphoma

Interventions: Drug: dasatinib

First Posted Date: 2009-06-11

Last Posted Date: 2018-08-31

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 2

Registration Number: NCT00918463

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: Docetaxel
Drug: Prednisone
Drug: 177Lu-J591

First Posted Date: 2009-06-09

Last Posted Date: 2021-05-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 15

Registration Number: NCT00916123

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇺🇸
University of North Carolina Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma

Phase 1

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Melphalan
Drug: Bendamustine

First Posted Date: 2009-06-09

Last Posted Date: 2019-06-04

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 57

Registration Number: NCT00916058

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients

Phase 2

Terminated

Conditions: Wiskott-Aldrich Syndrome
Bleeding
Thrombocytopenia

Interventions: Diagnostic Test: blood drawing in patients with WAS
Diagnostic Test: blood drawing in healthy controls
Drug: Promacta

First Posted Date: 2009-05-28

Last Posted Date: 2019-03-18

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 24

Registration Number: NCT00909363

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma

Phase 3

Terminated

Conditions: Cholangiocarcinoma

Interventions: Procedure: ERCP and Photodynamic Therapy
Procedure: ERCP only

First Posted Date: 2009-05-22

Last Posted Date: 2015-06-03

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 50

Registration Number: NCT00907413

Locations: 🇺🇸
University of Virginia, Charlotteville, Virginia, United States

Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)

Phase 2

Completed

Conditions: Immune Thrombocytopenia

Interventions: Drug: Eltrombopag
Drug: Romiplostim
Other: healthy controls

First Posted Date: 2009-05-14

Last Posted Date: 2019-03-18

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT00902018

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy